WednesdayJul 06, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Production Capabilities to Support Growing List of Business-to-Business Clientele

Lexaria is a global innovator in drug delivery platforms; its patented DehydraTECH(TM) technology improves the bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“API”)Testing confirms that DehydraTECH-processed cannabidiol beverages maintained 93.4% and 78% potency of CBD a full year and two years after production, respectivelyLexaria recently signed two agreements with BevNology LLC, an Atlanta-based company with advanced capabilities that support best-in-class beverage formulationsThe partnership, which also leverages Lexaria’s superior DehydraTECH-CBD nanoemulsification formulation and processing techniques, could make industry-leading beverage products a reality for many brands  In this year’s letter to shareholders, Lexaria Bioscience (NASDAQ: LEXX) Chair and…

Continue Reading

TuesdayJul 05, 2022 10:30 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Sees Robust Growth Within Their White-Labelled B2B Offering

The online gaming sector got its start in 1994, through the launch of MicrogamingThe sector has seen hundreds of online gaming platforms come online in the ensuing decades, with the vast majority opting to white-label their gaming offering from third-party providersGolden Matrix Group has sought to cater to this demand through its GMX-Ag platform, providing its customers with access to a portfolio of over 10,000 gamesGMGI’s focus on their white-label business was reflected in the 28% top-line growth seen within their B2B segment in their most recent fiscal quarter In 1994, a little-known company by the name of Microgaming based…

Continue Reading

TuesdayJul 05, 2022 10:15 am

Flora Growth Corp.’s (NASDAQ: FLGC) Management Confident in the Company’s Short, Medium, and Long-Term Growth Prospects

Flora just announced the repurchase of $5 million of its outstanding common sharesThis repurchase aligns with its overall global expansion plan, and its move to grow its market reachThese moves by Flora assure shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so On June 16, 2022, Flora Growth (NASDAQ: FLGC) announced that its Board of Directors had authorized the repurchase of up to $5 million of its outstanding common shares. This came in the wake of the expiration of a one-year lockup period for specific shareholders who had acquired shares before the company’s…

Continue Reading

FridayJul 01, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) Announces Plans to Boost OEM Initiatives with New Center of Excellence in Detroit and Inclusion in Russell 3000(R) Index

Cepton aims to increase active engagements and initiatives with automotive OEMs with a newly opened office located in Metro DetroitCPTN was added as a member to the Russell 3000(R) Index on June 27, 2022Cepton is a leading developer of lidar solutions for automotive (ADAS/AV), smart cities, smart spaces, and smart industrial applicationsCPTN management aims to make lidar a standard safety feature in the cars of today and the key component in the autonomous vehicles of the future Cepton (NASDAQ: CPTN) plans to utilize its new corporate office in Metro Detroit (Troy, MI) to widen its growing engagements and initiatives with…

Continue Reading

ThursdayJun 30, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Anticipates Continued Growth for Cannabis Operations Under New Colombian Administration

Flora Growth is a cannabis cultivator and distributor with a base of operations in Colombia’s fertile growing climate, capable of feeding the company’s expanding international supply chainColombia has undergone a number of regulatory changes in recent years as it emerges from the shadows of years-long drug wars and embraces a growing global acceptance of cannabis productsThe South American country voted in a new presidential administration in June, and Flora Growth is applauding the president-elect’s continued openness to international cannabis tradeFlora Growth announced significant revenue growth during its year-end financial reporting in May, and the company stated it expects another 288…

Continue Reading

ThursdayJun 30, 2022 9:00 am

No Debt and a Lot of Money Sets Golden Matrix Group Inc. (NASDAQ: GMGI) Apart as It Sets Sights on ESports Too

GMGI a standout differentiated in Benzinga’s Listmakers Series: ESportsGolden Matrix will be launching a new P2P ESports betting platformGMGI is eyeing new accretive acquisitions to extend its string of nearly 4 years of consecutive profitable quarters Companies are usually willing to open their bank accounts for naming rights. For instance, FedEx is paying $7.5 million per year to have their name on the home field of the Washington Commanders. New tech brands are changing the game. In November 2021, Crypto.com agreed to pay $700 million to see the iconic Staples Center re-branded as Crypto.com Center for the next 20 years…

Continue Reading

WednesdayJun 29, 2022 11:15 am

New Agreements Signed Between Lexaria Bioscience Corp. (NASDAQ: LEXX) and BevNology LLC; Pre-IND Meeting Request Filed with FDA

The two companies signed a manufacturing operating agreement and a commercial agreement Lexaria sent a pre-IND meeting request letter to the US FDA and plans to file the full IND application in late 2022/early 2023The FDA has acknowledged Lexaria's pre-IND request and responded with conditions prior to the target date of July 30, 2022 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has recently announced signing two agreements with BevNology LLC, the product and development arm of InterContinental Beverage Capital (“IBC”), operating its state-of-the-art lab and manufacturing facility just outside of Atlanta, Georgia. This announcement only furthers Lexaria's…

Continue Reading

TuesdayJun 28, 2022 1:30 pm

Zacks Report Highlights Flora Growth Corp. (NASDAQ: FLGC) Aspiring to Benefit from First Mover Advantage in Multiple Cannabis Market Categories

Flora’s 2021 acquisitions allowed it to expand its operations beyond North America and into EuropeAcquisitions have also contributed to 450% YOY revenue growth for Q1 2022Its management is confident that the foundation laid down so far will yield growth for 2022 and subsequent financial yearsFlora has also reiterated 2022 revenue guidance of $35 million to $45 million 2021 was an excellent year for Flora Growth (NASDAQ: FLGC). According to a recent research report from Zacks (https://ibn.fm/xnXve), the company possesses a number of important qualities pointing to continued significant growth following a strong 2021. Flora Growth management even regarded the past…

Continue Reading

TuesdayJun 28, 2022 12:00 pm

Mullen Automotive Inc. (NASDAQ: MULN) Retrofits Existing Facility to Move EV Battery Pack Production In-House

Global EV market projected to see 24.5% CAGR between 2022 and 2028MULN announces plans to modify high-voltage plant to produce packs used for company’s EVsCompany anticipates using its own revolutionary solid-state battery technology in its second-generation Mullen FIVE EV CrossoversStrategic move reduces company’s reliance on third-party suppliers, reduces impact of supply and critical component shortages Amid a growing global demand for electric vehicles (“EV”), smart companies operating in the space are looking for ways to differentiate themselves from the competition. That’s exactly what Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle manufacturer, has done with its recently announced plans to…

Continue Reading

TuesdayJun 28, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Authorizes New Channel Partner to Offer AditxtScore(TM) Amid Rising COVID-19 Cases and Possible Fall/Winter Waves

Aditxt, Inc. is a is a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system. The Company’s product AditxtScore(TM) is a proprietary immune mapping technology designed to provide a personalized profile of the immune system; AditxtScore(TM) for COVID-19 is the Aditxt’s first commercial productAditxt recently announced it had authorized a new channel partner – Premier Medical Laboratory Services (“PMLS”), a leading advanced medical diagnostics lab –to offer AditxtScore(TM)This announcement comes amid reports warning of a fall and winter COVID-19 wave occasioned by waning immunity or a possible “nasty new variant”Already, the U.S. is undergoing…

Continue Reading

Contact us: (512) 354-7000